相关实验视频

Updated: Mar 7, 2026

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

基于的抗微生物对抗抗卡巴胺耐药的Acinetobacter baumannii的作用:临床前药物评估和转化潜力

Hak Jun Lee¹, Seung Jun Lee², Yoon Hyun Sung¹

¹Institute of Emerging Infectious Diseases, Korea University, Seoul, Republic of Korea.

Frontiers in pharmacology

|March 6, 2026

概括

抗微生物DD-S052P在治疗耐卡巴胺抗性巴曼尼菌 (CRAB) 方面显示出有前途. 结合胆固醇,它在小鼠模型中实现了100%的存活率,为这种危险的感染提供了潜在的新疗法.

科学领域:

微生物学微生物学
传染性疾病传染性疾病
药物发现药物发现药物发现

背景情况:

耐卡巴胺的宝曼菌 (CRAB) 构成了严重的全球健康威胁,原因是治疗选择有限,患者的治疗结果不佳.
由于CRAB的出现,需要探索新的治疗策略来对抗多药耐药性感染.

研究的目的:

评估抗微生物DD-S052P作为对CRAB的辅助疗法的潜力.
评估DD-S052P与现有的抗生素对抗CRAB的协同作用和杀菌作用.

主要方法:

在体外 (in vitro) 确定协同作用和杀菌作用时,采用了棋盘方法和杀时试验.
用CRAB感染的小鼠模型来评估基于DD-S052P的组合疗法的疗效.
CRAB分离物来源于被诊断患有细菌病的患者的血液样本.

主要成果:

DD-S052P在体外表现出与安培/苏尔巴克坦,塞夫托洛/塔扎巴克坦和对抗CRAB分离物的胆固醇素的协同活性.
所有测试的组合都在时间杀死试验中显示出对CRAB的杀菌作用.
使用DD-S052P和胆固醇素的组合疗法在小鼠感染模型中导致100%的存活率.

结论:

与胆固醇结合的DD-S052P是一种有前途的治疗策略,用于治疗CRAB感染.
需要进一步的研究,以了解DD-S052P在克服碳胺耐药性的机制,并确认其临床实用性.

关键词:

这种细菌是Acinetobacter baumannii.动物模型动物模型抗微生物类的抗微生物.耐碳烯的耐碳烯的方法组合疗法治疗组合治疗.

更多相关视频

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

相关概念视频

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

Antimicrobial Proteins

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...